Anders Eric Karlsson

Allenex (Private Equity) (Allnex PE) is the private equity division of LinkMed AB (ST: LMED) in Sweden. Located in Stockholm, the firm was formerly known as LinkMed Private Equity, founded by Ingemar Lagerlöf in 1998. To assure the continued growth of their investee companies, Allnex PE has assembled a network of medical and managerial resources, divided into Corporate Operational Functions (Board and Management Team) and the Venture Management Network (Business Network and Scientific Advisory Board). The Venture Management Network provides guidance and strategic expertise to investee companies.

Part of CareDx, Inc., CareDx Lab Solutions, Inc. develops reagents and kits for low and high resolution human leukocyte antigen typing. The company is based in West Chester, PA. The CEO of the company is Anders Eric Karlsson.

Part of CareDx, Inc., Olerup GmbH develops reagents, diagnostic and genotyping kits for transplantation. The company is based in Vienna, Austria. The CEO of the Austrian company is Anders Eric Karlsson.

CareDx AB develops reagents and kits for low and high resolution human leukocyte antigen typing. Its products include Olerup SSP, Olerup QTYPE, Olerup XM-ONE, Olerup SBT and Olerup Gamma-Type. The comaony was founded by Olle Olerup in 1992 and is headquartered in Saltsjobaden, Sweden.

Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden.

Olerup International AB distributes molecular diagnostic products and services for human leukocyte antigen (HLA) typing and antibody detection. It offers transplant diagnostics and supportive software. The firm provides products and services for bone marrow and organ transplantation. Its HLA portfolio consists of two product lines, Sequence Specific Primer Genomic HLA Typing and Sequencing Based Typing. The company was founded in 2009 and is headquartered in Stockholm, Sweden.

AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden.